摘要
所谓早期胰腺癌是指肿瘤直径≤2cm,且局限于胰实质内,无胰腺外浸润及淋巴结转移,早期胰腺癌相当于TNM分期T1期。
出处
《岭南现代临床外科》
2009年第5期323-326,共4页
Lingnan Modern Clinics in Surgery
参考文献7
-
1金震东,蔡振寨,李兆申,邹多武,湛先保,陈洁,许国铭.内镜超声检查术对胰腺肿瘤早期诊断的价值[J].中华内科杂志,2007,46(12):984-987. 被引量:11
-
2C Salek,L Benesova,M Zavoral,V Nosek,L Kasperova,M Ryska,R Strnad,E Traboulsi,M Minarik.Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer[J].World Journal of Gastroenterology,2007,13(27):3714-3720. 被引量:18
-
3张韶光,张先富.胰腺癌肿瘤标志物的临床应用进展[J].中国医药导报,2007,4(06Z):9-11. 被引量:11
-
4陈锦武,袁宇红,詹俊.胰腺癌早期诊断55例临床分析[J].岭南急诊医学杂志,2006,11(6):413-414. 被引量:1
-
5朱庆云,李兆申,潘雪,孙振兴.检测Mesothelin蛋白表达对胰腺细针穿刺标本的诊断价值[J].中国医学科学院学报,2005,27(5):615-618. 被引量:1
-
6朱庆云,屠振兴,李兆申,满晓华.Mesothelin在胰腺癌组织的表达及其临床意义[J].胰腺病学,2005,5(1):17-20. 被引量:8
-
7Cosimo Sperti M.D.,Claudio Pasquali M.D.,Giandomenico Decet M.D.,Franca Chierichetti M.D.,Guido Liessi M.D.,Sergio Pedrazzoli M.D., F.A.C.S.. F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: A prospective study[J] 2005,Journal of Gastrointestinal Surgery(1):22~29
二级参考文献22
-
1朱庆云,屠振兴,李兆申,满晓华.Mesothelin在胰腺癌组织的表达及其临床意义[J].胰腺病学,2005,5(1):17-20. 被引量:8
-
2Argani P,Iacobuzio-Donahue C,Ryu B,et al. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res,2001,:3862-3868.
-
3Chang K,Pastan I. Molecular cloning of mesothelin,a differentiation antigen present on mesothelium,mesotheliomas,and ovarian cancers. Proc Natl Acad Sci USA,1996,3: 136-140.
-
4Bera TK,Pastan I. Mesothelin is not required for normal mouse development or reproduction. Mol Cell Biol,2000,0:2902-2906.
-
5Chang K,Pastan I,Willingham MC. Isolation and characterization of a monoclonal antibody,K1,reactive with ovarian cancers and normal mesothelium. Int J Cancer,1992,50:373-381.
-
6Chowdhury PS,Viner JL,Beers R,et al. Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity. Proc Natl Acad Sci USA,1998,95:669-674.
-
7Hassan R,Viner JL,Wang QC,et al. Anti-tumor activity of K1-LysPE38QQR,an immunotoxin targeting mesothelin,a cell-surface antigen overexpressed in ovarian cancer and malignant mesothelioma. J Immunother,2000,23:473-479.
-
8Kojima T,Oh-eda M,Hattori K,et al. Molecular cloning and expression of megakaryocyte potentiating factor cDNA. J Biol Chem,1995,270:21984-21990.
-
9Scholler N,Fu N,Yang Y,et al. Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma. Proc Natl Acad Sci USA,1999,96:11531-11536.
-
10Maguchi H. The roles of endoscopic uhrasonography in the diagnosis of pancreatic tumors. J Hepatobiliary Pancreat Surg, 2004,11:1-3.
共引文献44
-
1周海兵.以急性胰腺炎为首发症状的胰腺癌临床分析[J].中外医疗,2008,27(26).
-
2Alexander W Jahng,Sonya Reicher,David Chung,Donna Varela,Rahul Chhablani,Anil Dev,Binh Pham,Jose Nieto,Rose J Venegas,Samuel W French,Bruce E Stabile,Viktor E Eysselein.Staining for p53 and Ki-67 increases the sensitivity of EUS-FNA to detect pancreatic malignancy[J].World Journal of Gastrointestinal Endoscopy,2010,2(11):362-368. 被引量:3
-
3朱庆云,李兆申,潘雪,孙振兴.检测Mesothelin蛋白表达对胰腺细针穿刺标本的诊断价值[J].中国医学科学院学报,2005,27(5):615-618. 被引量:1
-
4孙备,孔瑞.肿块型慢性胰腺炎与胰头癌[J].临床外科杂志,2007,15(12):810-812. 被引量:11
-
5陈志荣,包怀鸣,徐天放,张春宝.肿瘤标志物mesothelin在胰腺癌组织的表达及其临床意义[J].标记免疫分析与临床,2008,15(6):359-361.
-
6金震东.超声内镜在消化系疾病诊治中的应用进展[J].胃肠病学和肝病学杂志,2009,18(1):5-9. 被引量:45
-
7申亚丽.血清CA19-9在消化道疾病诊断中的应用[J].中外医疗,2008,27(28):14-15.
-
8赵莉,张澍田,冀明,陈炳琪.管腔内超声检查对胰胆管疑难疾病的诊断价值[J].中华内科杂志,2009,48(8):625-628. 被引量:3
-
9李骥,傅德良.胰头部肿块定性诊断[J].中国实用外科杂志,2009,29(8):709-712. 被引量:1
-
10赵晶莹,邵春莹.K-ras基因突变与胰腺癌关系的研究进展[J].中国医药导报,2009,6(25):5-6. 被引量:1
同被引文献24
-
1胡先贵.努力提高胰腺癌术后长期生存率[J].第二军医大学学报,2005,26(8):842-844. 被引量:7
-
2Shimada K, Sakamoto Y, Sano Y, et al. Reapprasial of the clinical significant of tumor size in patients with pancreatic ductal carcino- ma[ J]. Pancreas,2006,33 (3) :233-239..
-
3Katz MH, Pisters PW, Evans DB, et al. Border/ine resectable pan- creatic cancer: the importance of this emerging stage of disease [ J ]. J Am Coil Surg,2008,206 (5) :833-846.
-
4Ishikawa O, Ohigashi H, Yamada T, et al. Radical resection for pancreatic cancer [ J ]. Acta Gastroenterol Belg, 2002, 65 ( 3 ) : 166-170.
-
5Yeo C J, Cameron JL, Lillemoe KD, et al. Pancreaticoduode-nectomy with or without distal gastrectomy and extended ret-roperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: ran- domized controlled trial evaluating survival, morbidity, and mortali- ty[ J]. Ann Surg,2002,236 ( 3 ) :355-368.
-
6Beget HG, Gansauge F, Leder G. Pancreatic cancer: who benefits from curative resection [ J ]. Can J Gastroenterol, 2002, 16 ( 2 ) : 117-120.
-
7Bilimoria KY, Bentrem D J, Ko CY, et al. Multimodality therapy for pancreatic cancer in the U. S. :utilization,outcomes,and the effect of hospital volume [ J ]. Cancer, 2007,110 ( 6 ) : 1227-1234.
-
8Di Carlo :, Gianotti L, Balzano G, et al. Complications of pancreat- ic surgery and the role of perioperative nutrition [ J ]. Dig Surg, 1999,16(4) :320-326.
-
9Halloran CM, Ghaneh P, Bosonnet L, et al. Complications of pan- creatic cancer resection [ J ]. Dig Surg,2002,19 (2) ; 138-146.
-
10Ellison NM, Chevlen E, Still CD, et al. Support care for patients with pancreatic adenocarcinoma: Symptom control and nutrition [ J ]. Hematol Oncol Clin North Am,2002,16 ( 1 ) : 105-121.
二级引证文献2
-
1吕秀娟,陈新,王艳,于杉,黄超.糖尿病对胰腺癌胰十二指肠切除术后并发症及生存情况的影响[J].中国当代医药,2016,23(23):64-66. 被引量:5
-
2张婷,杨丽,沈芳.团队协作干预在胰腺癌术后家庭肠内营养病人中的应用效果研究[J].肠外与肠内营养,2019,26(4):212-218. 被引量:10
-
1仇玲玲,付琼,黄雅萍,翟梅娟,杨俊杰.CD147和CD44v6在甲状腺乳头状癌中表达及其与侵袭转移的意义[J].现代实用医学,2013,25(6):640-641. 被引量:3
-
2张东兵,苏畅,杨振,冯劲峰,刘维燕.miRNA-613在甲状腺乳头状癌组织中的表达及其临床意义[J].医学临床研究,2014,31(6):1154-1156. 被引量:4
-
3王刚平,张念真,张作峰,张红.多灶性甲状腺乳头状癌中CD44v6和Survivin的表达及其意义[J].肿瘤研究与临床,2011,23(8):541-544.
-
4边学,殷玉林,李景慧.腺外浸润的甲状腺癌受侵气管壁的修复[J].耳鼻咽喉(头颈外科),2000,7(4):246-247. 被引量:3
-
5林维浩,马浙夫,夏浩明.甲状腺乳头状癌BRAF^(V600E)突变表达及其与临床病理特征的相关性研究[J].吉林医学,2015,36(14):2990-2992. 被引量:7
-
6赵月皎,石胜利,王静.影像检查对鉴别甲状腺肿瘤良恶性的意义[J].现代肿瘤医学,2005,13(5):631-632.
-
7李小强,张惠箴,蒋智铭,杜光烨,陆玲娟,董君波.甲状腺乳头状癌中BRAF基因的表达及意义[J].临床与实验病理学杂志,2012,28(9):991-995. 被引量:24
-
8刘洋,卢秀波,耿祖仕,樊玉霞,刘征,王晓明.微小RNA-21在不同甲状腺组织中的表达及其与乳头状癌临床特征间的关系[J].中华实验外科杂志,2013,30(11):2391-2393. 被引量:7
-
9李丹,郑高明.miR-221/222表达与甲状腺癌临床病理特征的关系[J].中国医师杂志,2015,17(7):981-983. 被引量:3
-
10关方霞,潘新良,解光,栾信庸.腺外浸润的晚期甲状腺癌的外科治疗[J].耳鼻咽喉(头颈外科),1999,6(2):103-106. 被引量:5